Please login to the form below

Not currently logged in
Email:
Password:

Envigo appoints Lizanne Muller as president, EMEA operations

And Craig Boyd joins from Mayne Pharma as chief commercial officer

Lizanne MullerContract research organisation Envigo has appointed Lizanne Muller as president of its EMEA operations.

She brings 18 years’ experience working within a multinational pharmaceutical manufacturing company, with 16 years spent at the Dishman Group serving in a variety of roles of increasing responsibility, including vice president of compliance and governance.

In her new role Muller will be accountable for Envigo’s contract research services and research services models operations across Europe and Asia.

Envigo has also appointed Craig Boyd as chief commercial officer.

He has more than 20 years’ experience in various global pharmaceutical markets and was previously executive vice president of Mayne Pharma’s US specialty brands division.

Prior to this, Craig led the global commercial sales functions at Hospira and Mylan, and spent 10 years as a senior commercial sales and marketing executive at Novartis.

Both will serve on the company’s executive committee and report to CEO Dr Adrian Hardy, who said both would bring great experience and knowledge to the firm.

He added: "Their experience and expertise will help us grow Envigo as we continue to focus on delighting our customers with great products and services. It’s a really exciting time at Envigo right now, with emphasis on enhancing our customers’ experience of working with us and cementing our presence as leaders in the markets we serve.”

28th September 2017

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics